Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective

Marcie Tomblyn(University of South Florida), Michael Boeckh(Fred Hutch Cancer Center)

Biology of Blood and Marrow Transplantation

September 10, 2009

10.1016/j.bbmt.2009.06.019

Cited by 1,773

Related Papers

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

|New England Journal of Medicine|2017|1.2k

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

|Blood|2010|477

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

|Blood|2003|442

Preventing Opportunistic Infections After Hematopoietic Stem Cell Transplantation: The Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and Beyond

|Hematology|2001|164

Viral disease prevention after hematopoietic cell transplantation

|Bone Marrow Transplantation|2009|148